Literature DB >> 21776985

Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.

Nubia Boechat1, Vitor F Ferreira, Sabrina B Ferreira, Maria de Lourdes G Ferreira, Fernando de C da Silva, Monica M Bastos, Marilia Dos S Costa, Maria Cristina S Lourenço, Angelo C Pinto, Antoniana U Krettli, Anna Caroline Aguiar, Brunno M Teixeira, Nathalia V da Silva, Priscila R C Martins, Flavio Augusto F M Bezerra, Ane Louise S Camilo, Gerson P da Silva, Carolina C P Costa.   

Abstract

The purpose of this study was to prepare various 4-substituted N-phenyl-1,2,3-triazole derivatives using click chemistry. The derivatives were screened in vitro for antimicrobial activity against Mycobacterium tuberculosis strain H37Rv (ATCC 27294) using the Alamar Blue susceptibility test. The activity was expressed as the minimum inhibitory concentration (MIC) in μg/mL (μM). Derivatives of isoniazid (INH), (E)-N'-[(1-aryl)-1H-1,2,3-triazole-4-yl)methylene] isonicotinoyl hydrazides, exhibited significant activity with MIC values ranging from 2.5 to 0.62 μg/mL. In addition, they displayed low cytotoxicity against liver cells (hepatoma HepG2) and kidney cells (BGM), thereby providing a high therapeutic index. The results demonstrated the potential and importance of developing new INH derivatives to treat mycobacterial infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21776985     DOI: 10.1021/jm2003624

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  Synthesis and Preliminary Evaluations of a Triazole-Cored Antagonist as a PET Imaging Probe ([18F]N2B-0518) for GluN2B Subunit in the Brain.

Authors:  Hualong Fu; Weiting Tang; Zhen Chen; Vasily V Belov; Genwei Zhang; Tuo Shao; Xiaofei Zhang; Qingzhen Yu; Jian Rong; Xiaoyun Deng; Wei Han; Scott J Myers; Pilar Giffenig; Lu Wang; Lee Josephson; Yihan Shao; April T Davenport; James B Daunais; Mikhail Papisov; Hongjie Yuan; Zijing Li; Stephen F Traynelis; Steven H Liang
Journal:  ACS Chem Neurosci       Date:  2019-02-27       Impact factor: 4.418

2.  Tandem synthesis of 1-formyl-1,2,3-triazoles.

Authors:  James T Fletcher; Joseph A Christensen; Eric M Villa
Journal:  Tetrahedron Lett       Date:  2017-10-13       Impact factor: 2.415

3.  Triazolbenzo[d]thiazoles: efficient synthesis and biological evaluation as neuroprotective agents.

Authors:  Belem Avila; Aaron Roth; Heather Streets; Donard S Dwyer; Mark J Kurth
Journal:  Bioorg Med Chem Lett       Date:  2012-07-20       Impact factor: 2.823

4.  Antitubercular activity of 1,2,3-triazolyl fatty acid derivatives.

Authors:  Diego G Ghiano; Agustina de la Iglesia; Nina Liu; Peter J Tonge; Héctor R Morbidoni; Guillermo R Labadie
Journal:  Eur J Med Chem       Date:  2016-09-28       Impact factor: 6.514

Review 5.  Progress in targeting cell envelope biogenesis in Mycobacterium tuberculosis.

Authors:  Mary Jackson; Michael R McNeil; Patrick J Brennan
Journal:  Future Microbiol       Date:  2013-07       Impact factor: 3.165

6.  Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells.

Authors:  Robson Xavier Faria; Daniel Tadeu Gomes Gonzaga; Paulo Anastácio Furtado Pacheco; André Luis Almeida Souza; Vitor Francisco Ferreira; Fernando de Carvalho da Silva
Journal:  J Bioenerg Biomembr       Date:  2018-02-23       Impact factor: 2.945

7.  Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.

Authors:  Ri-Zhen Huang; Gui-Bin Liang; Mei-Shan Li; Yi-Lin Fang; Shi-Feng Zhao; Mei-Mei Zhou; Zhi-Xin Liao; Jing Sun; Heng-Shan Wang
Journal:  Medchemcomm       Date:  2019-03-01       Impact factor: 3.597

8.  [1-(3-Chloro-phen-yl)-1H-1,2,3-triazol-4-yl]methanol hemihydrate.

Authors:  Nübia Boechat; Maria de Lourdes G Ferreira; Monica M Bastos; James L Wardell; Solange M S V Wardell; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-12

9.  Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking.

Authors:  Ashruba B Danne; Amit S Choudhari; Shakti Chakraborty; Dhiman Sarkar; Vijay M Khedkar; Bapurao B Shingate
Journal:  Medchemcomm       Date:  2018-04-11       Impact factor: 3.597

Review 10.  Triazole analogues as potential pharmacological agents: a brief review.

Authors:  Sachin Kumar; Sukhbir Lal Khokra; Akash Yadav
Journal:  Futur J Pharm Sci       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.